brexanolone | CARLAT PUBLISHING

Clinical Update

Diagnosing and Treating Postpartum Depression

October 3, 2023

Amanda Koire, MD, PhD. Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. Dr. Koire has no financial relationships with companies related to this material.

Postpartum depression is surprisingly common, yet often missed. We discuss screening techniques to ensure you won’t miss it, and share treatment approaches, including novel strategies like brexanolone, zuranolone, and TMS.

Expert Q&A

Management of Depression During Pregnancy and Breastfeeding

October 3, 2023

Karen Horst, MD

Karen Horst, MD.

Assistant Professor, Department of OB/GYN, Baylor College of Medicine; Medical Director, The Women’s Place, Pavilion for Women at Texas Children’s Hospital, Houston, TX.

Dr. Horst has no financial relationships with companies related to this material.

You might worry about prescribing antidepressants during pregnancy, but data on their safety is increasingly reassuring. We provide an in-depth review on how to treat depression in pregnancy and breastfeeding.

Zuranolone: 10 Questions about a New Antidepressant

August 14, 2023

Chris Aiken, MD

Zuranolone (Zurzuvae) is newly approved for postpartum depression, but does it work in regular depression? And why did they put so many “Zs” in the name?

Brexanolone: A New Treatment for Postpartum Depression

August 26, 2019

William S. Meyer is a clinical social worker and psychoanalytic psychotherapist who holds faculty positions at Duke in the Departments of Psychiatry and Ob/Gyn. He has spent 20 years working with postpartum depression at the Duke Medical Center. In this interview, he discusses the role of psychotherapy, community, family, and...